(Q42701943)

English

Analysis of CYP2C9 polymorphisms (2 and 3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (2 and3) with warfarin dose, age, PT and INR.

scientific article published on August 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Faiza Yasmeen

1

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Muhammad Bilal Ghafoor

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Abdul Wadood Khalid

3

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Waqas Latif

4

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Shahida Mohsin

5

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Shagufta Khaliq

6

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

publication date

1 August 2015

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Journal of Thrombosis and Thrombolysis

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

218-224

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Clinical significance of early thrombosis after prosthetic mitral valve replacement: a postoperative monocentric study of 680 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Warfarin: almost 60 years old and still causing problems

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Pharmacogenetics of warfarin elimination and its clinical implications

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

CYP2C9 allelic variants: ethnic distribution and functional significance

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Influence of CYP2C9 genetic polymorphisms on pharmacokinetics of celecoxib and its metabolites

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Evaluation of genetic factors for warfarin dose prediction

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Genetic-based dosing in orthopedic patients beginning warfarin therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Analysis of CYP2C9*5 in Caucasian, Oriental and black-African populations

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Frequency of cytochrome P450 2C9 mutant alleles in a Korean population

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Allele and genotype frequency of CYP2C9 in Tamilnadu population

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Influence of CYP2C9 genotype on warfarin dose requirements--a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

A pharmacogenetic versus a clinical algorithm for warfarin dosing

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Factors affecting warfarin dose requirements and quality of anticoagulation in adult Egyptian patients: role of gene polymorphism

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

CYP2C9 polymorphism and warfarin sensitivity in Taiwan Chinese

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Cost-effectiveness of dabigatran versus genotype-guided management of warfarin therapy for stroke prevention in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1215-5

21 January 2018

Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25904339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The human cytochrome P450 Allele Nomenclature Committee Web site: submission criteria, procedures, and objectives

1 reference

https://pubmed.ncbi.nlm.nih.gov/25904339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9

1 reference

https://pubmed.ncbi.nlm.nih.gov/25904339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese

1 reference

https://pubmed.ncbi.nlm.nih.gov/25904339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25904339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25904339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/25904339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population

1 reference

https://pubmed.ncbi.nlm.nih.gov/25904339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pharmacologic overview of current and emerging anticoagulants.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25904339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase

1 reference

https://pubmed.ncbi.nlm.nih.gov/25904339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11239-015-1215-5

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42701943&oldid=2205618948"